APP and Alzheimer disease: In recent years, several authors have defended that the absolute approach in the study of Aβ peptide (as a cause of amyloid plaques and AD) has resulted in APP itself, as well as its other proteolytic derivatives, being obviated in terms of possible therapeutic strategies of the disease [4].